Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/06/21 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/06/21 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/06/21 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/06/21 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/06/21 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/06/21 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/06/21 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 11/13/20 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
61 | |
| 11/12/20 | Current report filing |
|
9 | ||
| 11/09/20 | Current report filing |
|
6 |